Toll-Like Receptor Gene Polymorphisms Confer Susceptibility to Graft-Versus-Host Disease in Allogenic Hematopoietic Stem Cell Transplantation

Scandinavian Journal of Immunology

Volumn 76, Issue 3, 2012, Pages 336-341

  Sivula, J ^a   Cordova, Z M ^a,b   Tuimala, J ^a   Jaatinen, T ^a   Partanen, J ^a   Volin, L ^c   Turpeinen, H ^a  

^a FINNISH RED CROSS BLOOD SERVICE   (Finland)

^b Hospital Cínico Quirúrgico 'Hermanos Ameijeiras'   (Cuba)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

LEUKOCYTE ANTIGEN; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 10; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 6;

ADOLESCENT; ADULT; AGED; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; CHILD; FEMALE; GENETIC ASSOCIATION; GENETIC MARKER; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; GRAFT VERSUS HOST REACTION; HUMAN; INNATE IMMUNITY; MALE; PRIORITY JOURNAL; SCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ADULT; AGED; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; TOLL-LIKE RECEPTORS; TRANSPLANTATION, HOMOLOGOUS; YOUNG ADULT;

EID: 84865352586     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/j.1365-3083.2012.02737.x     Document Type: Article

References (15)

1. Mullighan CG, Bardy PG. New directions in the genomics of allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2007;13:127-44.
2. Hill GR, Ferrara JL. The primacy of the gastrointestinal tract as a target organ of acute graft-versus-host disease: rationale for the use of cytokine shields in allogeneic bone marrow transplantation. Blood 2000;95:2754-9.
3. Iwasaki A, Medzhitov R. Toll-like receptor control of the adaptive immune responses. Nat Immunol 2004;5:987-95.
4. Cooke KR, Gerbitz A, Crawford JM et al. LPS antagonism reduces graft-versus-host disease and preserves graft-versus-leukemia activity after experimental bone marrow transplantation. J Clin Invest 2001;107:1581-9.
5. Lorenz E, Schwartz DA, Martin PJ et al. Association of TLR4 mutations and the risk for acute GVHD after HLA-matched-sibling hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2001;7:384-7.
6. Elmaagacli AH, Koldehoff M, Hindahl H et al. Mutations in innate immune system NOD2/CARD 15 and TLR-4 (Thr399Ile) genes influence the risk for severe acute graft-versus-host disease in patients who underwent an allogeneic transplantation. Transplantation 2006;81:247-54.
7. Przepiorka D, Weisdorf D, Martin P et al. 1994 consensus conference on acute GVHD grading. Bone Marrow Transplant 1995;15:825-8.
8. Shulman HM, Sullivan KM, Weiden PL et al. Chronic graft-versus-host syndrome in man: a long-term clinicopathologic study of 20 Seattle patients. Am J Med 1980;69:204-17.
9. Ruutu T, Eriksson B, Remes K et al. Ursodeoxycholic acid for the prevention of hepatic complications in allogeneic stem cell transplantation. Blood 2002;100:1977-83.
10. Park JW, Beaty TH, Boyce P, Scott AF, McIntosh I. Comparing whole-genome amplification methods and sources of biological samples for single-nucleotide polymorphism genotyping. Clin Chem 2005;51:1520-3.
11. de Bakker PI, Yelensky R, Pe'er I et al. Efficiency and power in genetic association studies. Nat Genet 2005;37:1217-23.
12. International HapMap Consortium. The international HapMap project. Nature 2003;426:789-96.
13. Tobler AR, Short S, Andersen MR et al. The SNPlex genotyping system: a flexible and scalable platform for SNP genotyping. J Biomol Tech 2005;16:398-406.
14. Chuang T, Ulevitch RJ. Identification of hTLR10: a novel human toll-like receptor preferentially expressed in immune cells. Biochim Biophys Acta 2001;1518:157-61.
15. Penack O, Holler E, van den Brink MR. Graft-versus-host disease: regulation by microbe-associated molecules and innate immune receptors. Blood 2010;115:1865-72.